Dietary supplements in athletes

ACC Current Journal Review

Volumn 11, Issue 1, 2002, Pages 18-20

  Bove, Alfred A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CAFFEINE; CARDIOTONIC AGENT; CHONDROITIN; CREATINE; CYCLOSPORIN; EPHEDRA EXTRACT; EPHEDRINE; GAMMA BUTYROLACTONE; GLUCOSAMINE; HYPERICUM PERFORATUM EXTRACT; LIPID; UBIDECARENONE; WARFARIN;

AGITATION; ARTICLE; ARTICULAR CARTILAGE; ARTIFICIAL VENTILATION; ATHLETE; BASKETBALL; BREAST MALFORMATION; CARDIOMYOPATHY; COMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPHEDRA; ERECTILE DYSFUNCTION; FEMALE; FOOD AND DRUG ADMINISTRATION; GYNECOMASTIA; HEART ARRHYTHMIA; HEART FUNCTION; HUMAN; HYPERGLYCEMIA; HYPERICUM PERFORATUM; HYPERLIPIDEMIA; HYPERTENSION; INSOMNIA; MALE; MENSTRUATION DISORDER; MENTAL FUNCTION; MENTAL PERFORMANCE; MUSCLE GROWTH; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; SAFETY; SEIZURE; SLEEP INDUCTION; UNITED STATES; WELLBEING;

EID: 0036167621     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-1458(01)00534-7     Document Type: Review

References (10)

1. FDA talk paper: FDA warns about products containing gamma butyrolactone or GBL and asks companies to issue a recall. T99-5 21, Food and Drug Administration, U.S. Department of Health and Human Services, 1999(available at: http://www.fda.gov/bbs/topics/ANSWERS/ANS00937.html )
2. Perrotta DM, Coody G, Culmo C. Adverse events associated with ephedrine-containing products. JAMA 1996;276:1711–2.
3. Maron BJ, Shirani J, Poliac LC, Matherige R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. JAMA 1996;276:199–204.
4. Korkia P, Stimson GV. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med 1997;18:557–62.
5. Dickerman RD, Schaller F, McConathy WJ. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use. Cardiology 1998;90:145–8.
6. Yue QY, Bergquist C, Gerden B. Safety of St. John’s Wort (Hypericum perforatum) Lancet 2000;355:576–7.
7. Ruschitzka F, Meier PJ, Turina M, Luscher TF, Noll G. Acute heart transplant rejection due to Saint John’s wort. Lancet 2000;355:548–9.
8. Khatta M, Alexander BS, Krichten CM, et al. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med 2000;132:636–40.
9. http://dietary-supplements.info.nih.gov/databases/ibids.html
10. http://www.cfsan.fda.gov/∼dms/supplmnt.html